<DOC>
	<DOCNO>NCT01616277</DOCNO>
	<brief_summary>The purpose study determine study drug , PF-06252616 safe well tolerate give adult healthy volunteer .</brief_summary>
	<brief_title>A Phase 1 Study To Evaluate The Safety And Tolerability Of PF-06252616 In Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Single Dose CohortsHealthy male and/or female nonchild bearing subject age 18 55 year , inclusive . Repeat Dose CohortHealthy male and/or female nonchild bearing subject age 18 less 65 year , inclusive . Presence history muscle disease ( eg , polymyositis rhabdomyolysis ) . Weight loss gain &gt; 5 % within 30 day Screening , report subject . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , immunologic , metabolic urologic , dermatologic , renal , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) major disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>